Ectodysplasin A2 Receptor Antikörper
Kurzübersicht für Ectodysplasin A2 Receptor Antikörper (ABIN318757)
Target
Alle Ectodysplasin A2 Receptor (EDA2R) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- This antibody detects human X-linked ectodermal dysplasia receptor (XEDAR).
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human XEDAR.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: 0.5 - 2.0g/mL, detects a band of approximately 33 kDa in 293 cell lysates.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Phosphate buffered saline containing 0.02 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for up to one month or (in aliquots) at -20 °C for longer.
-
-
- Ectodysplasin A2 Receptor (EDA2R)
-
Andere Bezeichnung
- EDA2R / TNFRSF27
-
Hintergrund
- XEDAR is a 33kD type III transmembrane protein of the TNFR (tumor necrosis factor receptor) superfamily. XEDAR is a homologue of the ectodermal dysplasia receptor (EDAR), and binds to an isoform of ectodysplasin termed EDA-A2. Binding of ectodysplasin to XEDAR results in the induction of apoptosis, and is thought to be involved ectodermal organ development. New evidence suggests XEDAR may also be involved in skeletal muscle development. Two predominant isoforms of XEDAR exist, XEDAR-s and XEDAR-L, produced by alternative splicing.Synonyms: EDA-A2 receptor, Tumor necrosis factor receptor superfamily member 27, UNQ2448/PRO5727/PRO34080, X-linked ectodysplasin-A2 receptor, XEDAR
-
Gen-ID
- 60401
-
NCBI Accession
- NP_001186616
-
UniProt
- Q9HAV5
Target
-